Drug Shortage Report for AURO-ONDANSETRON ODT

Last updated on 2025-01-04 History
Report ID 242972
Drug Identification Number 02511282
Brand name AURO-ONDANSETRON ODT
Common or Proper name Auro-Ondansetron ODT
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) ONDANSETRON
Strength(s) 4MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1x10
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-11-14
Estimated end date 2024-12-31
Actual end date 2025-01-03
Shortage status Resolved
Updated date 2025-01-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-01-04 English Compare
v5 2025-01-03 French Compare
v4 2025-01-03 English Compare
v3 2024-11-15 English Compare
v2 2024-11-14 French Compare
v1 2024-11-14 English Compare

Showing 1 to 6 of 6